Abstract:Mutations in the phospholipase A2 Group 6 (PLA2G6) gene have been identified in autosomal recessive neurodegenerative diseases classified as infantile neuroaxonal dystrophy and neurodegeneration with brain iron accumulation. Recently, PLA2G6 was also reported as the causative gene for early-onset PARK14-linked dystonia-parkinsonism.To address whether PLA2G6 mutations are also an important cause of PD, we screened sequence variants of PLA2G6 in 250 PD patients and 550 controls in a Chinese Han populations. We identified four sequence changes: a coding synonymous c.1959T>A transition of exon13 in one patient, two missense mutations c.1966C>G in exon13 and c.2077C>G in exon14 in two different patients, which caused two amino acids change Leu656Val and Leu693Val respectively. We also found a frame-shift mutation P.His597fx69 in exon 12 in one patient. These four rare variants were not represented in 550 control individuals. Furthermore, we found that WT PLA2G6 enzyme hydrolyzed phospholipids while mutant PLA2G6 with P.His597fx69 frame-shift caused loss of enzyme activity, exhibiting less than 6% of the specific activity in phospholipase assays compared to that of WT PLA2G6. Mutant PLA2G6 with Leu656Val and Leu693Val decreased their activity by 45% and 35% in phospholipase assay respectively.We identified four rare PLA2G6 mutations in 250 PD patients, enlarging the spectrum of PLA2G6 mutations in PD. Although PLA2G6 mutations account for only a small fraction of PD patients in Chinese populations, these mutations impair catalytic activity of their phospholipids-hydrolyzing function. These results indicate that PLA2G6 mutations maybe PD-causing in Chinese Han populations.

Novel THAP1 Gene Mutations in Patients with Primary Dystonia from Southwest China.

THAP1/DYT6 sequence variants in non-DYT1 early-onset primary dystonia in China and their effects on RNA expression

1.261 THAP1/DYT6 SEQUENCE VARIANTS IN NON-DYT1 EARLY ONSET PRIMARY DYSTONIA IN CHINA AND THEIR EFFECTS ON RNA EXPRESSION

Clinical and Genetic Evaluation of DYT1 and DYT6 Primary Dystonia in China

A Novel Tyrosine Hydroxylase Variant in a Group of Chinese Patients with Dopa-Responsive Dystonia.

Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita.

Combined Occurrence of a Novel TOR1A and a THAP1 Mutation in Primary Dystonia

Subcellular distribution of THAP1 and alterations in the microstructure of brain white matter in DYT6 dystonia

Clinical Feature And Dyt1 Mutation Screening In Primary Dystonia Patients From South-West China

Late-Onset Primary Dystonia in Zhejiang Province of China: A Service-Based Epidemiological Study

Analysis of Clinical Phenotype and CGH1 Gene Mutations in a Family Affected with Dopa-Responsive Dystonia

DYT1 MUTATIONS AMONGST EARLY ONSET PRIMARY DYSTONIA PATIENTS IN CHINA

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Mutation Analysis of Ganglioside-Induced Differentiation Associated Protein-1 Gene in Chinese Charcot-Marie-Tooth Disease

Three Novel Mutations of the Spastin Gene in Chinese Patients with Hereditary Spastic Paraplegia

Mutation Screening of GNAL Gene in Patients with Primary Dystonia from Northeast China.

Study of GCH1 and TH genes in Chinese patients with Parkinson's disease.

Lack of Association Between TOR1A and THAP1 Mutations and Sporadic Adult-Onset Primary Focal Dystonia in a Chinese Population.

Novel GCH1 mutation and clinical study Chinese patients with dopa-responsive dystonia

Association of Rs1182 Polymorphism of the DYT1 Gene with Primary Dystonia in Chinese Population.

GTP Cyclohydrolase I and Tyrosine Hydroxylase Gene Mutations in Familial and Sporadic Dopa-Responsive Dystonia Patients.